EUVIMEDEUVIMED entdecken
Multizentrische Studie

Metabolic‐associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy

N M Batt iD, B Rodrigues iD, S Bloom iD, R Sawhney, E S George iD, A Hodge iD, N Vootukuru, C McCrae, Surbhi Sood, S K Roberts iD, A Dev, S Bell und 6 weitere

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16501 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von N M Batt und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Eastern Health, Box Hill, Victoria, Australia. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Metabolic Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim The rising incidence of hepatocellular carcinoma (HCC) in Australia is related to increasing rates of metabolic‐associated fatty liver disease (MAFLD). This study aimed to prospectively characterize the metabolic profile, lifestyle, biometric features, and response to treatment of HCC patients in an Australian population.

Method

Multicenter prospective cohort analysis of newly diagnosed HCC patients at six multidisciplinary team meetings over a 2‐year period.

Results

Three hundred and thirteen (313) newly diagnosed HCC patients with MAFLD ( n = 77), MAFLD plus other liver disease ( n = 57) (the “mixed” group), and non‐MAFLD ( n = 179) were included in the study. Alcohol‐associated liver disease (ALD) (43%) and MAFLD (43%) were the most common underlying liver diseases. MAFLD‐HCC patients were older (73 years vs 67 years vs 63 years), more likely to be female (40% vs 14% vs 20%), less likely to have cirrhosis (69% vs 88% vs 85%), showed higher ECOG, and were less likely to be identified by screening (29% vs 53% vs 45%). Metabolic syndrome was more prevalent in the MAFLD and mixed groups. The severity of underlying liver disease and HCC characteristics were the same across groups. While the MAFLD population self‐reported more sedentary lifestyles, reported dietary patterns were no different across the groups. Dyslipidemia was associated with tumor size, and those taking statins had a lower recurrence rate.

Conclusion

Equal to ALD, MAFLD is now the most common underlying liver disease seen in HCC patients in Australia. Future HCC prevention screening and treatment strategies need to take this important group of patients into consideration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMetabolic SyndromeHumansFemaleMaleProspective StudiesMiddle AgedAgedAustraliaLife StyleTreatment OutcomeFatty LiverNon-alcoholic Fatty Liver DiseaseCohort Studies

Stichwörter der Autor:innen

HCCLifestyleLiver cancerMAFLDMetabolic syndrome

Autor:innen und Institutionen

  • Department of Gastroenterology, Eastern Health, Box Hill, Victoria, Australia.
  • Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia.
  • Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia.
  • Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Department of Gastroenterology, Monash Health, Clayton, Victoria, Australia.

ORCID-Profile: N M Batt, B Rodrigues, S Bloom, E S George, A Hodge, S K Roberts, W Kemp

Zitieren

APA

Batt, N. M., Rodrigues, B., Bloom, S., Sawhney, R., George, E. S., Hodge, A., Vootukuru, N., McCrae, C., Sood, S., Roberts, S. K., Dev, A., Bell, S., Thompson, A., Ryan, M. C., Kemp, W., Gow, P. J., Sood, S., & Nicoll, A. J. (2024). Metabolic‐associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16501

Vancouver

Batt NM, Rodrigues B, Bloom S, Sawhney R, George ES, Hodge A, et al. Metabolic‐associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16501

BibTeX
@article{Batt2024,
  author = {Batt, N M and Rodrigues, B and Bloom, S and Sawhney, R and George, E S and Hodge, A and Vootukuru, N and McCrae, C and Sood, Surbhi and Roberts, S K and Dev, A and Bell, S and Thompson, A and Ryan, M C and Kemp, W and Gow, P J and Sood, Siddharth and Nicoll, A J},
  title = {Metabolic‐associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16501}
}
Kostenlos starten →